Shareholders who lost money in shares Charming Medical Ltd. (NASDAQ: MCTA) Should Contact Wolf Haldenstein Immediately

(NASDAQ:MCTA), NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers Charming Medical Ltd. (NASDAQ: MCTA) (“Charming”) that a federal securities class action has been filed on behalf of investors who purchased Integer between October 21, 2025 and November 12, 2025, inclusive (the “Class Period”). Investors […]

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Alexandria Real Estate Equities, Inc. (NYSE: ARE)

(NYSE:ARE), NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Alexandria Real Estate, Inc. (“Alexandria” or the “Company”) (NYSE: ARE) between January 27, 2025 through October 27, 2025, inclusive

Shareholders who lost money in shares Charming Medical Ltd. (NASDAQ: MCTA) Should Contact Wolf Haldenstein Immediately

Shareholders who lost money in shares Charming Medical Ltd. (NASDAQ: MCTA) Should Contact Wolf Haldenstein Immediately Lead Plaintiff Deadline is February 17, 2026 GlobeNewswire January 12, 2026 NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers Charming Medical Ltd. (NASDAQ: MCTA) (“Charming”) that a federal

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Alexandria Real Estate Equities, Inc. (NYSE: ARE)

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Alexandria Real Estate Equities, Inc. (NYSE: ARE) GlobeNewswire January 12, 2026 NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”)

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women’s Hospital, a world-class academic medical center, to analyze peripheral blood samples from patients living with rheumatoid

Gulshan Management Services, Inc. Data Breach Alert Issued By Wolf Haldenstein

PLEASE CLICK HERE TO SUBMIT YOUR CONTACT INFORMATION NEW YORK and CHICAGO, Jan. 12, 2026 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a preeminent national consumer rights law firm, is investigating claims on behalf of people who have been impacted by the Gulshan Management Services, Inc. (“Gulshan”) data breach. Gulshan,

HCLTech to partner with The Magnum Ice Cream Company to modernize its digital foundation

HCLTech (NSE: HCLTECH.NS) (BSE: HCLTECH.BO), a leading global technology company, has entered into a multi-year partnership to design, build and manage a future-ready IT infrastructure for The Magnum Ice Cream Company (TMICC), the world’s largest ice cream company. In the coming years, HCLTech will deploy its AI Force platform to embed AI across TMICC’s digital

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to power precision oncology 10x also plans to establish a CLIA-certified laboratory to enable development of future innovative diagnostic tests 10x Genomics, Inc. (Nasdaq: TXG), a leader in

Gulshan Management Services, Inc. Data Breach Alert Issued By Wolf Haldenstein

Gulshan Management Services, Inc. Data Breach Alert Issued By Wolf Haldenstein GlobeNewswire January 12, 2026 PLEASE CLICK HERE TO SUBMIT YOUR CONTACT INFORMATION NEW YORK and CHICAGO, Jan. 12, 2026 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a preeminent national consumer rights law firm, is investigating claims on behalf of

Lexaria Releases Annual Letter from the CEO

KELOWNA, BC / ACCESS Newswire / January 12, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provide this Annual Letter from its Chief Executive Officer ("CEO") Richard Christopher as a strategic update to all stakeholders. CEO Letter to Stakeholders Dear Fellow Stakeholders, I’m

Scroll to Top